| Literature DB >> 27023558 |
Christina Zong-Hao Ma1,2, Duo Wai-Chi Wong3, Wing Kai Lam4, Anson Hong-Ping Wan5, Winson Chiu-Chun Lee6,7.
Abstract
Falls and fall-induced injuries are major global public health problems. Balance and gait disorders have been the second leading cause of falls. Inertial motion sensors and force sensors have been widely used to monitor both static and dynamic balance performance. Based on the detected performance, instant visual, auditory, electrotactile and vibrotactile biofeedback could be provided to augment the somatosensory input and enhance balance control. This review aims to synthesize the research examining the effect of biofeedback systems, with wearable inertial motion sensors and force sensors, on balance performance. Randomized and non-randomized clinical trials were included in this review. All studies were evaluated based on the methodological quality. Sample characteristics, device design and study characteristics were summarized. Most previous studies suggested that biofeedback devices were effective in enhancing static and dynamic balance in healthy young and older adults, and patients with balance and gait disorders. Attention should be paid to the choice of appropriate types of sensors and biofeedback for different intended purposes. Maximizing the computing capacity of the micro-processer, while minimizing the size of the electronic components, appears to be the future direction of optimizing the devices. Wearable balance-improving devices have their potential of serving as balance aids in daily life, which can be used indoors and outdoors.Entities:
Keywords: balance; falls; force sensors; inertial motion sensors; real-time biofeedback; sensory augmentation; wearable sensors
Mesh:
Year: 2016 PMID: 27023558 PMCID: PMC4850948 DOI: 10.3390/s16040434
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Overview of the sensing mechanism of wearable sensors.
| Type of Wearable Sensor | Outcome Measurement | Location of Sensor | |
|---|---|---|---|
| Inertial motion sensor | Accelerometer | Linear acceleration of X, Y, and Z movements in a three dimensional space | Body segment |
| Gyroscope | Angular velocity: extent and rate of rotation in a three dimensional space (roll, pitch, and yaw) | Body segment | |
| Magnetometer | Direction: absolute angular movements relative to the Earth’s magnetic field | Body segment | |
| Planter force sensor | Plantar force/pressure information | Plantar surface of foot | |
Figure 1Flow chart of searching results and screening strategy.
Levels of Evidence (Oxford Centre for Evidence-based Medicine—March 2009) [107].
| Level | Therapy/Prevention, Aetiology/Harm |
|---|---|
| Systematic Review (with homogeneity) of Randomized Controlled Trials | |
| Individual Randomized Controlled Trial (with narrow Confidence Interval) | |
| All or none | |
| Systematic Review (with homogeneity) of cohort studies | |
| Individual cohort study (including low quality Randomized Controlled Trial; e.g., <80% follow-up) | |
| “Outcomes” Research; Ecological studies | |
| Systematic Review (with homogeneity) of case-control studies | |
| Individual Case-Control Study | |
| Case-series (and poor quality cohort and case-control studies) | |
| Expert opinion without explicit critical appraisal, or based on physiology, bench research or “first principles” |
Grades of Recommendation (Oxford Centre for Evidence-based Medicine—March 2009) [107].
| Grade | Contents |
|---|---|
| consistent level 1 studies | |
| consistent level 2 or 3 studies or extrapolations from level 1 studies | |
| level 4 studies or extrapolations from level 2 or 3 studies | |
| level 5 evidence or troublingly inconsistent or inconclusive studies of any level |
The Downs and Black Quality List [108].
| Subscale | Item | Index | Score | |||||
|---|---|---|---|---|---|---|---|---|
| 5 | 4 | 3 | 2 | 1 | 0 | |||
| Is the hypothesis/aim/objective of the study clearly described? | - | - | - | - | Y | N | ||
| Are the main outcomes to be measured clearly described in the Introduction or Methods section? | - | - | - | - | Y | N | ||
| Are the characteristics of the patients included in the study clearly described? | - | - | - | - | Y | N | ||
| Are the interventions of interest clearly described? | - | - | - | - | Y | N | ||
| Are the distributions of principal confounders in each group of subjects to be compared clearly described? | - | - | - | Y | P | N | ||
| Are the main findings of the study clearly described? | - | - | - | - | Y | N | ||
| Does the study provide estimates of the random variability in the data for the main outcomes? | - | - | - | - | Y | N | ||
| Have all important adverse events that may be a consequence of the intervention been reported? | - | - | - | - | Y | N | ||
| Have the characteristics of patients lost to follow-up been described? | - | - | - | - | Y | N | ||
| Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001? | - | - | - | - | Y | N | ||
| Were the subjects asked to participate in the study representative of the entire population from which they were recruited? | - | - | - | - | Y | N/UD | ||
| Were those subjects who were prepared to participate representative of the entire population from which they were recruited? | - | - | - | - | Y | N/UD | ||
| Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? | - | - | - | - | Y | N/UD | ||
| Was an attempt made to blind study subjects to the intervention they have received? | - | - | - | - | Y | N/UD | ||
| Was an attempt made to blind those measuring the main outcomes of the intervention? | - | - | - | - | Y | N/UD | ||
| If any of the results of the study were based on “data dredging”, was this made clear? | - | - | - | - | Y | N/UD | ||
| In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is the time period between the intervention and outcome the same for cases and controls? | - | - | - | - | Y | N/UD | ||
| Were the statistical tests used to assess the main outcomes appropriate? | - | - | - | - | Y | N/UD | ||
| Was compliance with the intervention/s reliable? | - | - | - | - | Y | N/UD | ||
| Were the main outcome measures used accurate (valid and reliable)? | - | - | - | - | Y | N/UD | ||
| Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited from the same population? | - | - | - | - | Y | N/UD | ||
| Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited over the same period of time? | - | - | - | - | Y | N/UD | ||
| Were study subjects randomised to intervention groups? | - | - | - | - | Y | N/UD | ||
| Was the randomised intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable? | - | - | - | - | Y | N/UD | ||
| Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? | - | - | - | - | Y | N/UD | ||
| Were losses of patients to follow-up taken into account? | - | - | - | - | Y | N/UD | ||
| Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%? | Size of smallest intervention group | |||||||
| > | < | |||||||
-Note: Y: yes; P: partially; N: no; UD: unable to determine.
Level of evidence and grade of recommendation (n = 17).
| Study | Level of Evidence | Design | Level of Recommendation |
|---|---|---|---|
| Afzal | 3B | Individual Case-Control Study | B |
| Byl | 1B | Individual Randomized Controlled Trial | A |
| Crea | 3B | Individual Case-Control Study | B |
| Grewal | 1B | Individual Randomized Controlled Trial | A |
| Ma | 3B | Individual Case-Control Study | B |
| Caudron | 3B | Individual Case-Control Study | B |
| Halicka | 3B | Individual Case-Control Study | B |
| Franco | 3B | Individual Case-Control Study | B |
| Nanhoe-Mahabier | 3B | Individual Case-Control Study | B |
| Nataraj | 3B | Individual Case-Control Study | B |
| Sungkarat | 1B | Individual Randomized Controlled Trial | A |
| Alahakone | 3B | Individual Case-Control Study | B |
| Janssen | 3B | Individual Case-Control Study | B |
| Giansanti | 3B | Individual Case-Control Study | B |
| Lee | 3B | Individual Case-Control Study | B |
| Chiari | 3B | Individual Case-Control Study | B |
| Wall | 3B | Individual Case-Control Study | B |
Assessing results of the Downs and Black Quality List (n = 17).
| Study | Score of Subscale and Index | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reporting | External Validity | Internal Validity-Bias | Internal Validity-Confounding (Selection Bias) | Power | Total | |||||||||||||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | ||
| Afzal | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 17 |
| Byl | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 19 |
| Crea | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 15 |
| Grewal | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 25 |
| Ma | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 19 |
| Caudron | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 17 |
| Halicka | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 17 |
| Franco | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 18 |
| Nanhoe-Mahabier | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 20 |
| Nataraj | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 15 |
| Sungkarat | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 23 |
| Alahakone | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 15 |
| Janssen | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 17 |
| Giansanti | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 16 |
| Lee | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 18 |
| Chiari | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 15 |
| Wall | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 15 |
Subject characteristics (n = 17).
| Study | Sample Size (Gender, F/M) | Group (Sample Size, n): Mean (SD) Age, Years | Sample Characteristics | ||
|---|---|---|---|---|---|
| Physical | Cognitive | Fall History | |||
| Afzal | 9 (1/8) | Intervention (9): | -Stroke: clear symptoms of lower-limb weakness at the paretic side. | Not specified | Not specified |
| -Stroke (4): 64.8 (9.5) | |||||
| -Healthy (5): 26.2 (3.3) | |||||
| Byl | 24 (8/16) | Intervention (12): | -With gait impairments and one year or more post stroke or diagnosis of PD. | -Able to follow instructions | Not specified |
| -PD (7): 68.5 (3.6) | |||||
| -Stroke (5): 66.2 (5.0) | |||||
| Control (12): | |||||
| -PD (5): 70 (2.9) | |||||
| -Stroke (7): 60.8 (5.4) | |||||
| Crea | 10 (6/4) | Intervention (10): 27.0 (1.8) | -Able-bodied | Not specified | Not specified |
| Grewal | 39 (20/19) | Intervention (19): 62.6 (8.0) | -Type 2 diabetes with peripheral neuropathy; able to independently walk for 2m. | No cognitive dysfunction | Not specified |
| Control (20): 64.9 (8.5) | |||||
| Ma | 30 (13/17) | Intervention (30): | -Fully independent, living in a community-based setting, and were capable of ambulation without assistive devices. | Able to follow instructions | Not specified |
| -Elderly (15): 70.1 (3.7) | |||||
| -Young (15): 26.7 (2.9) | |||||
| Caudron | 17 (7/10) | Intervention (17): 61.9 (8.2) | -Patients with idiopathic PD. | Not specified | With or without |
| Halicka | 20 (11/9) | Intervention (20): 22.6 (nil) | Healthy young subjects did not report any neurological, orthopaedic, or balance impairments. | Not specified | Not specified |
| Franco | 20 (11/9) | Intervention (20): 26.5 (3.7) | Healthy young subjects with no history of sensory or motor problems, neurological diseases, or disorders. | Not specified | Not specified |
| Nanhoe-Mahabier | 20 (4/16) | Intervention (10): 59.3 (2.0) | -Patients with PD. | No cognitive dysfunction | Not specified |
| Control (10): 58.6 (2.5) | |||||
| Nataraj | 1 (1/0) | Intervention (1): nil (nil) | Patient with thoracic-4 level complete paraplegia. | Not specified | Not specified |
| Sungkarat | 35 (11/24) | Intervention (17): 52.1 (7.2) | -Patients with first episode of unilateral stroke with hemiparesis; orpington prognostic score at initial assessment between 3.2 and 5.2 (moderately severe); able to walk at least 10 m with or without assistance; stable medical condition; and to participate. | No impaired cognition and/or communication | Not specified |
| Control (18): 53.8 (11.2) | |||||
| Alahakone | 6 (3/3) | Intervention (6): 23.2 (nil) | Healthy young subjects | Not specified | Not specified |
| Janssen | 20 (8/12) | Intervention (10): 63.1 (9.3) | Patients with severe bilateral vestibular losses (flexia or hyporeflexia). | Not specified | >5 times falls per year |
| Control (10): 40-65 | |||||
| Giansanti | 9 (nil) | Intervention (9): 55.0 (33-71) | Healthy subjects | Not specified | Not specified |
| Lee | 7 (2/5) | Intervention (7): 38.9 (14.1) | Lower-limb amputees with no orthopaedic or neurological conditions, disabling arthritis, uncorrected visual problems, dizziness or vertigo, use of assistive walking devices, joint injury, or joint implants | Not specified | Not specified |
| Chiari | 9 (nil) | Intervention (9): 55.0 (33-71) | Healthy subjects | Not specified | Not specified |
| Wall | 6 (4/2) | Intervention (6): 24.8 (22-29) | Healthy subjects | Not specified | Not specified |
Device characteristics (n = 17).
| Study | Type of Sensors | Location of Sensors | Type of Biofeedback | Function of Device |
|---|---|---|---|---|
| Afzal | Plantar force sensors | Heel, toe, 1st and 5th MT heads | Vibrotactile | Diagnose gait abnormalities and provide vibration feedback to help compensate for the asymmetric gait. |
| Byl | Plantar force sensors | Toe, 1st and 2nd MTP, 4th and 5th MTP, and heel | Visual | Gait training with visual kinematic feedback on iPad. |
| Accelerometer | Shank and thigh | |||
| Magnetometer | ||||
| Gyroscope | ||||
| Crea | Plantar force sensors (64 at each insole) | Plantar surface of the foot | Vibrotactile | Provide simultaneous vibration based on the detected gait phase transitions. |
| Grewal | Accelerometer | Shank, thigh and lower back | Auditory & Visual | Provide audio-visual feedback on a display of the sway of COM and ankle joints |
| Magnetometer | ||||
| Gyroscope | ||||
| Ma | Plantar force sensors | Heel, 1st and 5th MT heads | Vibrotactile | Provide vibrotactile feedback of postural sway. |
| Caudron | Accelerometer | Cranial vertex and the spine processes of the T7-T8 | Visual | Real time biofeedback of anterior-posterior trunk and head tilts |
| Magnetometer | ||||
| Halicka | Accelerometer | Posterior side of T4, L5 | Visual | Capture body sway and provide visual biofeedback |
| Force plate | ||||
| Franco | Accelerometer | Posterior side of L5 | Auditory | Monitor the trunk angular evolution during bipedal stance and improve user’s balance through auditory biofeedback by earphone |
| Magnetometer | ||||
| Gyroscope of a smartphone | ||||
| Nanhoe-Mahabier | Angular velocity sensors | Lower back at level L1-L3 | Vibrotactile | Deliver vibrotactile feedback of trunk sway to head |
| Nataraj | Accelerometer | Pelvis and torso | Electrotactile | Estimate COM acceleration using inputs from body-mounted accelerometer measurements. |
| Deliver stimulation via surgically implanted intramuscular electrodes to bilateral muscle groups of trunk and lower limb | ||||
| Sungkarat | Plantar force sensors | Heel of the paretic foot | Auditory | Rehabilitation and gait training based on footswitch and the amount of weight bearing at the paretic limb |
| Alahakone | Accelerometer | Lower back | Vibrotactile & Visual | Measure the ML trunk tilt angles |
| Gyroscope | Custom-developed software for data processing, data display and feedback generation | |||
| Temperature sensor | ||||
| Janssen | Accelerometer | Head or upper trunk | Vibrotactile | Detect head or body tilt |
| Deliver vibrotactile biofeedback to the waist. | ||||
| Giansanti | Accelerometer | Body centre of mass (COM). | Auditory | Assess the trunk sway and provide biofeedback information |
| Gyroscope | ||||
| Lee | Plantar force sensors | Heel and the 3rd MT head of the prosthetic foot | Electrical & Visual-auditory | Detect heel strike and toe off. |
| Provide sub-threshold low-level electrical stimulation to the quadriceps, and visual-auditory biofeedback on a screen | ||||
| Chiari | Accelerometer | Trunk | Auditory | Measure the linear accelerations of the trunk in anteroposterior and mediolateral directions |
| Provide audio-biofeedback via headphones | ||||
| Wall | Accelerometer | Head | Vibrotactile | Measure lateral head tilt and mount vibrotactile elements on the body to display head tilt |
| Gyroscope |
Study outcome characteristics (n = 17).
| Study | Assessment Point | Outcome Measures | Measurement Tool | Results | Balance Improvement |
|---|---|---|---|---|---|
| Afzal | (1) Pre-test | -Postural stability during standing;
| Smartphone with inertial sensors | (1) Vibration cue based on temporal information was more effective than intensity information | Yes, static and dynamic balance |
| (2) Post-test | (2) Individuals with stroke revealed significant improvement in gait symmetry with minimal disturbance caused to the balance and gait speed as an effect of the biofeedback. | ||||
| Byl | (1) Pre-test | -Mobility (gait speed, step length, endurance, and quality)
| -Force sensors | (1) All subjects revealed significant gains in mobility, balance, range of motion and strength. | Yes, dynamic balance |
| (2) Post-test | (2) Subjects with chronic post stroke achieved greater strength gains on the affected side than subjects with PD. | ||||
| (3) 6 weeks | (3) Dynamic visual kinematic feedback from wireless pressure and motion sensors had similar positive effects as verbal and therapist feedback. | ||||
| Crea | (1) Pre-test | -No. of correct/wrong detection of gait phrases
| -Questionnaire | (1) High recognition of feedback information | Yes, dynamic balance |
| (2) Post-test | (2) Time-discrete low-intensity feedback was readily perceived by humans and potentially can assist gait control | ||||
| Grewal | (1) Pre-test | Postural stability during standing | Inertial motion sensors | (1) Significant reduction in COM sway after training. | Yes, static balance |
| (2) A higher postural stability deficit (high body sway) at baseline was associated with higher training gains in postural balance (reduction in COM sway). | |||||
| (2) Post-test | (3) Significant improvement in postural coordination between the ankle and hip joints. | ||||
| Ma | (1) Pre-test | Postural stability during standing; | Force plate | Significant reduction in COP sway after training. | Yes, static balance |
| (2) Post-test | |||||
| Caudron | (1) Pre-test | -Postural stability
| Motion capture system using reflective markers | Visual biofeedback improved PD patients’ postural orientation and postural stability | Yes, static balance |
| (2) Post-test | |||||
| Halicka | (1) Pre-test | -COP
| -Force plate | (1) Reduction of body sway was the most significant in the body segment upon receiving the visual biofeedback. | Yes, static balance |
| (2) Post-test | (2) The COP position and L5 position provided the best signals for visual biofeedback. | ||||
| Franco | (1) Pre-test | Postural stability during standing | Inertial motion sensors | Young healthy individuals were able to efficiently use auditory biofeedback on sagittal trunk tilt to improve their balance in the medial-lateral direction. | Yes, static balance |
| (2) Post-test | |||||
| Nanhoe-Mahabier | (1) Pre-test | Postural stability during standing | Angular velocity sensors | (1) Patients in the feedback group had a significantly greater reduction in ML and AP postural sway. | Yes, static balance |
| (2) Post-test | (2) Greater ML sway angle in controls after training suggested better training effects in the feedback group | ||||
| Nataraj | (1) Pre-test | Postural stability during standing | Motion capture system using reflective markers | Compared with constant muscle stimulation employed clinically, controlled stimulations based on COM acceleration improved standing performance more and reduced the upper limb loading required to resist internal postural disturbances by 27% | Yes, static balance |
| (2) Post-test | |||||
| Sungkarat | (1) Pre-test | Gait speed, step length and single support time asymmetry ratio, balance and amount of load on paretic leg during stance | -Motion capture system | (1) The experimental group demonstrated significant increase in standing and gait symmetry compared with the control group. | Yes, static and dynamic balance |
| (2) The experimental group demonstrated three times greater improvement in gait speed than the control group. | |||||
| (2) 3 weeks (60 min × 5 days/week) | (3) Balance improvement was significantly greater for the experimental than the control group | ||||
| Alahakone | (1) Pre-test | ML trunk sway during tandem Romberg standing tests | -Inertial motion sensors | (1) Feedback was triggered 100% of the time when trunk tilt exceeded the defined threshold. | Yes, static balance |
| (2) Post-test | (2) Significant reduction in trunk tilt angle. | ||||
| Janssen | (1) Pre-test | Body sway during standing (COP) | Force plate | (1) No significant change in body sway path was observed using biofeedback in six subjects. | Partially yes, static balance |
| (2) In four patients, body sway path decreased significantly using biofeedback and sensor on the head in all three activation modes, whereas with sensor on the trunk only one patient showed a significant improvement in sway path in all three activation modes. | |||||
| (2) Post-test | (3) However, the improvement with true biofeedback was only observed in those subjects where an improvement was present in placebo mode as well. | ||||
| Giansanti | (1) Pre-test | Changes in angular sway and kinetic energy variables | Inertial motion sensors | Using auditory biofeedback, all subjects significantly reduced pitch, roll and angular velocity with eyes open or closed while standing on a foam surface | Yes, static balance |
| (2) Post-test | |||||
| Lee | (1) Pre-test | -Single leg quiet standing balance | Motion capture system | (1) Improvement in balance performance during single leg quiet standing by applying sub-sensory stimulation. | Yes, static and dynamic balance |
| (2) Post-test | (2) With visual-auditory biofeedback as a cue for heel contact and toe push-off condition during treadmill ambulation, the dynamic gait performance of amputees was improved. | ||||
| Chiari | (1) Pre-test | Postural stability during standing | Force plate | (1) Improved balance upon using the audio-biofeedback system and this improvement was greater when the subject’s balance was challenged by absent or unreliable sensory cues. | Yes, static balance |
| (2) Post-test | (2) High correlations were found between the COP displacement and trunk acceleration | ||||
| Wall | (1) Pre-test | -Lateral head sway | -Inertial motion sensors | Reduced lateral postural sway upon using the head tilt information. | Yes, static balance |
| (2) Post-test |
Figure 2Overview of effectiveness of the devices and type of sensors.